Health

Halving world hunger by 2015 'within reach', UN says

Despite economic crises and dwindling aid, the UN said Monday huge progress had been made towards meeting the so-called Millennium Development Goals, including its bid to slash world hunger in half between 1990 and 2015.

Medications

Roche extends its hostile takeover bid for Illumina

Swiss pharmaceutical group Roche said Monday it is sticking by its hostile $5.7-billion (4.2 billion euros) bid for US gene mapper Illumina and is extending it for a month.

Diseases, Conditions, Syndromes

Trump deploys emergency beds, global pandemic deaths surge

US President Donald Trump ordered thousands of emergency hospital beds set up at American coronavirus hotspots but a trillion-dollar economic rescue package crashed, as pandemic deaths soared across the globe.

Vaccination

Investors pan for gold in rush for coronavirus vaccine

With the race on to find a coronavirus vaccine, the biotech sector—from an investor's point of view—appears to be the new gold rush, promising often giddy returns, but analysts warn that the exuberance could be exaggerated.

Medications

Reckitt pays US $1.4bn to settle opioid treatment spat

British consumer health giant Reckitt Benckiser announced Thursday it will pay up to $1.4 billion (1.2 billion euros) to settle a dispute with US authorities over the sale and marketing of an opioid addiction treatment.

Vaccination

US funding sees Covid-19 antibody trial enter next phase

UK pharmaceuticals group AstraZeneca said on Monday it will advance trials of a Covid-19 treatment to a crucial third stage, after the United States invested $486 million (411 million euros) in its development.

Vaccination

Vaccine innovation sparks hope, questions

Reports that one of the vaccines for COVID-19 has shown highly promising results are a ray of hope for a world in the shadow of surging virus cases.

page 8 from 14